Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer | Scientific Reports
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
CA125, YKL-40, HE-4 and Mesothelin: a new serum biomarker combination in discrimination of benign and malign epithelial ovarian tumor
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
Distribution of tumor marker levels in various patient groups. Box... | Download Scientific Diagram
Elecsys® CA 125 II
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
The CA 125 “tumor associated protein” or “tumor marker” - CancerConnect
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
CA 125 II
PDF) Preoperative CA-125 Levels in 123 Patients With Borderline Ovarian Tumors
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy - Gynecologic Oncology
Serum CA 125 is of clinical value in the staging and follow‐up of patients with non‐hodgkin's lymphoma - Lazzarino - 1998 - Cancer - Wiley Online Library
![PDF] Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/06c3dcc8efc9a1f23e1d101401973faade359a6c/2-Table1-1.png "PDF] Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. | Semantic Scholar")
PDF] Pediatric population reference value distributions for cancer biomarkers and covariate-stratified reference intervals in the CALIPER cohort. | Semantic Scholar
JCM | Free Full-Text | CA125 as a Marker of Heart Failure in the Older Women: A Population-Based Analysis | HTML
Frontiers | Bispecific T-Cell Engaging Antibodies Against MUC16 Demonstrate Efficacy Against Ovarian Cancer in Monotherapy and in Combination With PD-1 and VEGF Inhibition | Immunology
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
Cancer Antigen 125 during Pregnancy in Women without Ovarian Tumor Is Not Often Rising
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis - ScienceDirect
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
Exosomal CA125 as A Promising Biomarker for Ovarian Cancer Diagnosis
